Skip to main content

Table 2 Clinical review of the literature

From: Erotomania and phenotypic continuum in a family frameshift variant of AUTS2: a case report and review

Authors

Sultana et al. [5] (on twins of de la Barra et al. [22]

Kalscheuer et al. [23]

Bakkaloglu et al. [24]

Huang et al. [25]

Nagamani et al. [13]

Jolley et al. [12]

Amarillo et al. [6]

Liu et al. [26]

Schneider et al. [27]

Fan et al. (2015) [14]

Beunders et al. [11]

Beunders et al. [18]

Sengun et al. [28]

Saeki et al. (2019)

This report

Group / family

Monozygotics twins

Unrelated

Indiv.

Indiv.

Unrelated (2); Siblings (2)

Indiv.

Indiv.

Indiv.

Indiv.

Unrelated

Unrelated

Unrelated (11) et family (2)

Indiv.

Indiv.

Family

Number

2

3

1

1

4

1

1

1

1

3

2

13

1

1

4

Sex

F (2/2)

M (2/3), F (1/3)

M

M

M (1/1),

F (2/3)

M

F

M

M

M (1/3), F (2/3)

M (2/2)

M (5/13)

F (8/13)

F

M

M (1/4), F (3/4)

Mean age (years) and standard deviation

16 (0)

4, 27, 17

4.5 (0)

4.7 (0)

10 3 10 3

13 (0)

4.5 (0)

4

8.4 (0)

8 8.5 6

20, 24

6 16 7 28 40 23 5 10 59 38 5 1?

68 (0)

8 (0)

13 45 49 50

Genetic alteration involving AUTS2

Deletion / Duplication / Mutation

Breakpoint between exons 2 and 3

t(7;20) (q11.2;p11.2)

t(7;20) (q11.2;p11.2)

Breakpoint between exons 2–5; 5–6; 5–7

(Transloc.)

Breakpoint within intron 5

inv. (7)(q11.22q35);inv. (7)

Breakpoint within intron 1

(Transloc.)

Deletion of exon 6–14(×2); and duplication of exon 5(× 2)

Size: 133 to 319; 179 (2)

Deletion of exon 3–6

o.(Gln107*)

Size: 683–806

Deletion of exon 6

Size: 62

Distal deletion of exon 1

Size: 830

Breakpoint between intron 2 and 6, size 89 (Transloc.)

Deletion of exon 6(×2); 12–19(×1), Size: 98; 2147; 262

Deletion of exon 7; 6

p.(Lys286fs) / chr7.hg 19:g.(69985843_69991859)_(70,221,259_70,228,020)del

Deletions of exon 2–4 (× 2); 5(×3); 1–5(× 1); 6(× 2); 6–9(× 1); 9 fs(× 1);7st(× 1); 15–17; all deleted

Size: 50 to 4.5 Mb

Deletion of exon 6 and flanking introns 5 and 6

Size:

257

Deletion of exon 8

(p.Tyr488*)

(3b)

Duplication of exon 11–19

p.(Met593Tyrfs*85)

Inherited / De novo

De novo

De novo (3)

De novo

De novo

De novo (1)

Inherited (2)

Parent not available (1)

De novo

De novo

De novo

De novo

De novo (3)

De novo

De novo (9)

Not available (2)

Inherited (2)

Not available

De novo

Inherited

Neurodevelopment

Developmental delay

2/2

1/3 (2/3 na)

1/1

1/1

4/4

1/1

1/1

1/1

3/3

3/3

2/2

+ (9/13)

1/1

1/1

2/4

Intellectual Deficiency

Severe (2/2)

Severe (1/3)

Borderline (1/3)

Moderate (1/3)

1/1 (type na)

na

DQ: 5-year-old at 10 (1/4)

Vocabulary: 3 words at 3 (1/4)

Mild-moderate (2/4)

Intellectual disability (na)

na (“no full sentances”)

DQ: significantly delayed;

Developmental age: 11 months (at 4 years old)

Developmental age: 4 years (at 8 years

IQ below 40 (2/3)

IQ below 45 (1/3)

Moderate intellectual disability, IQ 45 (1/2)

IQ between 60 and 70 (1/2)

Mild borderline (5/13)

Mild (3/13)

Moderate (5/13)

Mild-Moderate

1/1 (type na)

Severe (1/4)

Mild-Moderate (1/4)

ASD

2/2

?

1/1

1/1

2/4 (related)

0/1

?

1/1

2/3

2/3

2/2

10/13

1/1

1/1

2/4

ADHD

na

2/2, na

na

na

na

0/1

1/1

3/3

3/3

1/2

7/13

1/1

1/1

Neurological disorders

Generalized hypotonia

na

3/3

1/1

4/4

1/1

1/1

1/3

1/3

5/13

1/1

2/4

Structural brain anomaly

- (EEG)

1/1, na (2)

1/1

na

0/2; na (2)

0/1

1/3

1/3

1/13

Hypertonia/spasticity

1/2

1/3

na

na

na

1/1

1/1

7/13

na

Epilepsy

2/2

1/3

1/4

- (one seizure)

Na (EEG normal)

2/3

2/3

na

2/13

na

Growth

Low birth weight < p3

0/2

na

1/2

na

1/1

Short stature < p10

2/2

3/3

1/3; na (1)

1/1

1/1

2/3

2/3

1/2

12/13

1/1

1/1

4/4

Microcephaly < p2

1/2

na

na

na

1/4

1/1

1/3

1/3

2/2

10/12

1/1

1/1

Feeding problems

na

3/3

1/1

na

1/1

 

na

 

2/3

2/2

11/13

1/1

1/1

1/4

Sleep disturbance

na

1/3

na

na

na

na

 

na

 

na

na

1/13

na

na

1 or 2/4

Dysmorphic features

?

+ (2/3)

+ (1/1)

+ (3/4)

+ (1/1)

+ (3/3)

+ (3/3)

+ (2/2)

+

+ (1/1)

+ (1/1)

4/4

Skeletal abnormalities (Kyphosis/scoliosis or feet deformities)

+ (2/2)

+ (1/3)

na

na

1/4

na

+ (1/1)

1/3

1/3

+ (2/2)

+ (5/13)

+ (1/1)

- (1/1)

+ (4/4)

  1. The number in brackets indicates the number of cases for each study. fs: frameshift mutation; st: stop mutation; Size /kb; Transloc. Translocation; Del. Deletion; Dup. Duplication; EEG Electroencephalography; (nb) number of bases; na not available